Cell therapy is stuck in the pre-AI age. The number of cell therapy ideas and candidates that can be tested in parallel is throttled because manufacturing them is slow and expensive. The result? Slow drug development and poor outcomes for the patients in greatest need.

CellEcho Biotech is building a fully automated, AI-integrated cell therapy design-build-test-learn platform to slash the current iteration cycle time from months to days.

We are building the Model T production line for cell therapies, finding the best by making and testing hundreds of candidates per weekly iterative loop.